Back to search

Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice

Data up to Jan 2025

Published2007
Citations163
References107

Total Citations Per Year

Abstract

References (107)

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

2012 • 10,051 citations

Mild cognitive impairment as a diagnostic entity

2004 • 7,048 citations

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

1996 • 4,118 citations

Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles

2003 • 3,802 citations

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

1998 • 3,404 citations

Pathways towards and away from Alzheimer's disease

2004 • 2,936 citations

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1992 • 2,520 citations

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

1991 • 2,375 citations

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment

2002 • 1,912 citations

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

2004 • 1,637 citations

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

2000 • 1,498 citations

Depression and Risk for Alzheimer Disease

2006 • 1,348 citations

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

2000 • 1,259 citations

Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

2005 • 1,206 citations

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus

1996 • 1,200 citations

Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex

2003 • 933 citations

Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

2004 • 928 citations

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease

2003 • 928 citations

Molecular and Neuronal Substrate for the Selective Attenuation of Anxiety

2000 • 927 citations

BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders

2004 • 893 citations

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

1991 • 887 citations

Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice

2005 • 859 citations

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

2003 • 811 citations

Essential Role for TrkB Receptors in Hippocampus-Mediated Learning

1999 • 797 citations

Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective

1999 • 733 citations

Individual Differences in Trait Anxiety Predict the Response of the Basolateral Amygdala to Unconsciously Processed Fearful Faces

2004 • 674 citations

The Use of the Morris Water Maze in the Study of Memory and Learning

1989 • 665 citations

Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

2005 • 649 citations

Positron emission tomography in Alzheimer's disease

1986 • 563 citations

E<scp>PIDEMIOLOGY OF</scp>N<scp>EURODEGENERATION</scp>

2003 • 513 citations

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

2002 • 508 citations

cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment

2000 • 503 citations

Region-Specific Neurotrophin Imbalances in Alzheimer Disease

2000 • 499 citations

Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

1998 • 493 citations

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

1995 • 488 citations

Acetylcholine modulation of neural systems involved in learning and memory

2003 • 440 citations

Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease

2002 • 423 citations

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

2003 • 417 citations

NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults

1994 • 402 citations

BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies

1999 • 387 citations

Cortical abnormalities in Alzheimer's disease

1984 • 378 citations

Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease

2005 • 370 citations

New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

1998 • 364 citations

Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF

2004 • 318 citations

Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

2004 • 318 citations

Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat

1975 • 310 citations

Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease

2005 • 306 citations

Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides

2000 • 292 citations

Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice

2003 • 282 citations

Relative Roles of Plaques and Tangles in the Dementia of Alzheimer's Disease: Correlations Using Three Sets of Neuropathological Criteria

1995 • 281 citations

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

2000 • 259 citations

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

2004 • 256 citations

Bi-phasic change in BDNF gene expression following antidepressant drug treatment

2003 • 244 citations

Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice

2001 • 229 citations

Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: A mechanism to facilitate encoding and circuit maintenance?

1998 • 228 citations

Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease

2001 • 224 citations

Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease

1999 • 221 citations

β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised

2001 • 211 citations

Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice

2001 • 199 citations

Emotional Memory: In Search of Systems and Synapsesa

1993 • 189 citations

Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor

2003 • 179 citations

Tau gene mutations: dissecting the pathogenesis of FTDP-17

2002 • 174 citations

Specific spatial learning deficits become severe with age in β-amyloid precursor protein transgenic mice that harbor diffuse β-amyloid deposits but do not form plaques

2001 • 162 citations

Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant

2003 • 157 citations

Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models

2006 • 148 citations

Influence of Paroxetine, Branched-Chain Amino Acids and Tyrosine on Neuroendocrine System Responses and Fatigue in Humans

1998 • 140 citations

Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings

2004 • 140 citations

Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety

2004 • 129 citations

Does my mouse have Alzheimer's disease?

2002 • 129 citations

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms

2005 • 121 citations

Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen‐activated protein kinase pathway

2001 • 118 citations

Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease

1991 • 116 citations

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels

2006 • 112 citations

Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease

1994 • 111 citations

Interactions of Amyloidogenic Proteins

2003 • 111 citations

Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders

2003 • 110 citations

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

2003 • 105 citations

The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain

2001 • 105 citations

Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus

2002 • 103 citations

Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats

1999 • 96 citations

Amygdala cell loss and atrophy in Alzheimer's disease

1992 • 94 citations

Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology

2006 • 94 citations

Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment

2005 • 92 citations

Paroxetine retards disease onset and progression in Huntingtin mutant mice

2004 • 91 citations

Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant

2004 • 81 citations

Sex differences in serotonergic activity in dorsal and median raphe nucleus

2003 • 70 citations

Functional Neurochemistry of Alzheimers Disease

2004 • 65 citations

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

2005 • 62 citations

Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine

2002 • 62 citations

GABA-A and 5-HT1A Receptor Agonists Block Expression of Fear-Potentiated Startle in Mice

2002 • 57 citations

Affinity Purification of Human τ Proteins and the Construction of a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay for Human τ Detection

1992 • 48 citations

FDA-Preapproved Drugs Targeted to the Translational Regulation and Processing of the Amyloid Precursor Protein

2004 • 46 citations

Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer’s dementia

1990 • 42 citations

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimers APP 5Untranslated Region

2005 • 41 citations

Toward Alzheimer Therapies Based on Genetic Knowledge

2004 • 40 citations

Spotlight on Paroxetine in Psychiatric Disorders in Adults*

2002 • 31 citations

Restraint stress induces β-amyloid precursor protein mRNA expression in the rat basolateral amygdala

2004 • 25 citations

Effect of LTP-reinforcing paradigms on neurotransmitter release in the dentate gyrus of young and aged rats

2004 • 25 citations

Evaluation of [3H]paroxetine as an in vivo ligand for serotonin uptake sites: A quantitative autoradiographic study in the rat brain

1993 • 24 citations

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review

2002 • 23 citations

Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice

2005 • 20 citations

The amygdala in down's syndrome and familial Alzheimer's disease: Four clinicopathological case report

1991 • 19 citations

Laterality in the Histological Effects of Injections of Amyloid-β 25-35 into the Amygdala of Young Fischer Rats

1997 • 17 citations

Alzheimer's disease: From molecular biology to neuropsychiatry

2003 • 13 citations

Clinical and Molecular Aspects of Frontotemporal Dementia

2004 • 10 citations

Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.

1998 • 8 citations

Cited By (0)

Loading...